Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Regular aspirin intake and acute myocardial infarction.

Literature DB >> 4816857

Regular aspirin intake and acute myocardial infarction.

Abstract

The results of two large independent studies involving a combined total of 776 patients treated in hospital with a discharge diagnosis of acute myocardial infarction and 13,898 patients with other discharge diagnoses showed a negative association between regular aspirin intake and non-fatal myocardial infarction. The data are consistent with the hypothesis that aspirin protects against this disease. Clinical trials are needed to determine whether this hypothesis is correct.

Entities: Chemical Disease Species

Mesh：

Substances：
Aspirin

Year: 1974 PMID： 4816857 PMCID： PMC1633212

Source DB: PubMed Journal: Br Med J ISSN： 0007-1447

7 in total

1. Statistical aspects of the analysis of data from retrospective studies of disease.

Authors: N MANTEL; W HAENSZEL
Journal: J Natl Cancer Inst Date: 1959-04 Impact factor: 13.506

2. Impaired platelet-connective-tissue reaction in man after aspirin ingestion.

Authors: H J Weiss; L M Aledort
Journal: Lancet Date: 1967-09-02 Impact factor: 79.321

3. Effects of salicylates on human platelets.

Authors: J R O'Brien
Journal: Lancet Date: 1968-04-13 Impact factor: 79.321

4. Coffee and myocardial infarction.

Authors: H Jick; O S Miettinen; R K Neff; S Shapiro; O P Heinonen; D Slone
Journal: N Engl J Med Date: 1973-07-12 Impact factor: 91.245

5. Factors influencing the age of menarche in a lower socio-economic group in Melbourne.

Authors: B Jones; J Leeton; I McLeod; C Wood
Journal: Med J Aust Date: 1972-09-02 Impact factor: 7.738

6. The effect of salicylates on the hemostatic properties of platelets in man.

Authors: H J Weiss; L M Aledort; S Kochwa
Journal: J Clin Invest Date: 1968-09 Impact factor: 14.808

7. A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction.

Authors: P C Elwood; A L Cochrane; M L Burr; P M Sweetnam; G Williams; E Welsby; S J Hughes; R Renton
Journal: Br Med J Date: 1974-03-09

7 in total

10 in total

Review 4. Platelets, thrombosis and drugs.

Authors: J F Mustard; M A Packham
Journal: Drugs Date: 1975 Impact factor: 9.546

5. Antiplatelet agents in coronary disease: are they of prophylactic value?

Authors: M Verstraete
Journal: Drugs Date: 1978-06 Impact factor: 9.546

Review 6. Antithrombotic drugs: part II.

Authors: A S Gallus; J Hirsh
Journal: Drugs Date: 1976 Impact factor: 9.546

Review 7. Aspirin in cardiovascular disease.

Authors: I A Reilly; G A FitzGerald
Journal: Drugs Date: 1988-02 Impact factor: 9.546

Regular aspirin intake and acute myocardial infarction.

1. Statistical aspects of the analysis of data from retrospective studies of disease.

2. Impaired platelet-connective-tissue reaction in man after aspirin ingestion.

3. Effects of salicylates on human platelets.

4. Coffee and myocardial infarction.

5. Factors influencing the age of menarche in a lower socio-economic group in Melbourne.

6. The effect of salicylates on the hemostatic properties of platelets in man.

7. A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction.

1. Prophylactic agents for thrombosis.

Review 2. The current role of platelet-active drugs in ischaemic heart disease.

3. Learning how to control biases in studies to identify adverse effects of drugs: a brief personal history.

Review 4. Platelets, thrombosis and drugs.

5. Antiplatelet agents in coronary disease: are they of prophylactic value?

Review 6. Antithrombotic drugs: part II.

Review 7. Aspirin in cardiovascular disease.

Review 8. Antiplatelet drugs: clinical pharmacology and therapeutic use.

9. Thiazolidinediones and Parkinson Disease: A Cohort Study.

10. A corpus of potentially contradictory research claims from cardiovascular research abstracts.